540729 — Vanta Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	26.5	2.24	0.966	1.61	2.22
Net Total Accounts Receivable
Net Total Receivables	60.2	63.2	73.4	89.2	81.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	199	145	152	172	154
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	349	373	332	284	240
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	696	814	847	854	859
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	148	143	177	229	266
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	457	574	672	702	755
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	239	240	175	152	104
Total Liabilities & Shareholders' Equity	696	814	847	854	859
Total Common Shares Outstanding